Early phase | Maintenance phase | ||||||||
---|---|---|---|---|---|---|---|---|---|
Univariate analysis | Multivariate regression analysis | Univariate analysis | Multivariate regression analysis | ||||||
Characteristics | Categories | P value | Standardized Coefficient | P value | P value | Standardized Coefficient | P value | ||
Age, CCa | − 0.073 | 0.061 | − 0.111 | 0.007 | − 0.098 | 0.010 | − 0.134 | < 0.001 | |
BMI, CCa | − 0.299 | < 0.001 | 0.447 | < 0.001 | − 0.348 | < 0.001 | 0.456 | < 0.001 | |
Type of cancer, cm (SD)b | Cervical cancer | − 7.20 (7.53) | 0.268 | referent | − 9.65 (9.64) | 0.008 | referent | ||
Endometrial cancer | − 6.26 (7.01) | 0.034 | 0.444 | − 7.40 (9.64) | 0.087 | 0.037 | |||
Ovarian cancer | − 6.27 (7.37) | 0.014 | 0.755 | − 7.28 (8.81) | 0.029 | 0.484 | |||
Lymphadenectomy, cm (SD)b | Pelvic | − 4.45 (9.90) | 0.014 | referent | − 8.46 (12.05) | < 0.001 | referent | ||
Pelvic + paraaorta | − 6.57 (8.17) | − 0.022 | 0.596 | − 4.78 (9.29) | − 0.055 | 0.132 | |||
Chemotherapy, cm (SD)b | Yes | − 2.88 (10.66) | 0.002 | 0.011 | 0.825 | − 1.75 (11.24) | < 0.001 | − 0.010 | 0.140 |
No | − 6.88 (9.24) | − 8.29 (8.28) | |||||||
Radiotherapy, cm (SD)b | Yes | − 7.28 (12.29) | 0.242 | 0.108 | 0.012 | − 9.11 (14.53) | 0.074 | 0.082 | 0.040 |
No | − 6.35 (8.22) | − 7.16 (9.65) | |||||||
Stage, cm (SD)b | I | − 1.53 (5.32) | < 0.001 | referent | − 0.13 (4.66) | < 0.001 | referent | ||
II | − 5.81 (7.61) | 0.044 | 0.704 | − 6.97 (9.32) | − 0.168 | 0.141 | |||
Late in II | − 9.61 (10.57) | 0.053 | 0.640 | − 11.96 (12.65) | − 0.093 | 0.407 | |||
III | − 27.32 (31.34) | 0.01 | 0.849 | − 31.76 (38.43) | − 0.056 | 0.260 | |||
Circumference, CCa | − 0.608 | < 0.001 | − 0.828 | < 0.001 | − 0.671 | < 0.001 | − 0.920 | < 0.001 | |
MLD, cm (SD)b | Yes | − 6.54 (9.35) | 0.768 | 0.013 | 0.794 | − 8.17 (11.52) | 0.012 | 0.011 | 0.796 |
No | − 6.87 (9.40) | − 5.40 (8.60) |